Martingale Asset Management’s PharMerica Corporation PMC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-51,224
Closed -$1.79M 892
2015
Q4
$1.79M Buy
51,224
+7,844
+18% +$246K 0.04% 331
2015
Q3
$1.24M Buy
43,380
+35,980
+486% +$1.21M 0.03% 406
2015
Q2
$247K Buy
+7,400
New +$227K 0.01% 803
2014
Q3
Sell
-55,872
Closed -$1.6M 936
2014
Q2
$1.6M Buy
55,872
+1,557
+3% +$43.3K 0.05% 368
2014
Q1
$1.52M Buy
54,315
+2,611
+5% +$64.1K 0.05% 358
2013
Q4
$1.11M Buy
+51,704
New +$940K 0.04% 497

Other funds holding PMC

Martingale Asset Management's PMC Position: Q1 2016 in Review

Martingale Asset Management sold out of PharMerica Corporation (PMC) in Q1 2016, closing a stake of 51,224 shares — an estimated $1.79M sold.

Martingale Asset Management first reported a position in PMC in Q4 2013 and held it in 6 quarters. The position peaked at $1.79M in Q4 2015. 169 funds tracked by Wall St. Rank hold PMC as of Q1 2016.

  • Martingale Asset Management reported no remaining PharMerica Corporation position as of Q1 2016 after selling out during the quarter.
  • Martingale Asset Management sold 51,224 PharMerica Corporation shares in Q1 2016, an estimated $1.79M.
  • Martingale Asset Management first reported a position in PharMerica Corporation in Q4 2013 and held it in 6 quarters.
  • Martingale Asset Management's PharMerica Corporation position peaked at $1.79M in Q4 2015.
  • 169 funds tracked by Wall St. Rank held PharMerica Corporation as of Q1 2016.

Based on Martingale Asset Management's 13F filing for Q1 2016, filed 11 May 2016.